Correlates of tumor size, gender, cell type, and metastasis of resected non-small cell lung cancer and age

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 51, Issue 1, 1996, Pages

  Pendleton, N ^a   Jefferson, M F ^a   Dixon, G R ^b   Myskow, M W ^b   Horan, M A ^a  

^a MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^b Broadgreen Hospital   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CELL TYPE; FEMALE; HUMAN; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; SEX DIFFERENCE; TUMOR CELL; TUMOR VOLUME;

ANIMALIA;

EID: 0030043956     PISSN: 10795006     EISSN: None     Source Type: Journal    
DOI: 10.1093/gerona/51A.1.B50     Document Type: Article

References (36)

1. Altman, D.G. Relation between several variables. In: Altman, D.G., ed. Practical statistics for medical research. London: Chapman and Hall, 1992a:325-361.
2. Altman, D.G. Comparing groups - continuous data In: Altman, D.G., ed. Practical statistics for medical research. London: Chapman and Hall, 1992b:179-223.
3. Ambrosone, C.B., Rao, U.; Michalek, A.M.; Cummings, K.M.; Mettlin, C.J. Lung cancer histological types and family history of cancer. Analysis of histological subtypes of 872 patients with primary lung cancer. Cancer 72:1192-1198; 1993.
4. Cohen, M.C.; Mathews, M.J. Small cell bronchogenic carcinoma: a distinct clinicopathological entity. Semin. Oncol. 5:234-244; 1978.
5. Dodds, L.; Davis, S.; Polissar, L. A population-based study of lung cancer incidence trends by histologic type, 1974-1981. J. Natl. Cancer Inst. 76:21-29; 1986.
6. Elias, A. Chemotherapy and radiotherapy for regionally advanced non-small cell lung cancer. Chest 103 (suppl):362s-366s; 1993.
7. Ershler, W.B. Geriatric correlates of experimental tumour biology Oncology 6 (suppl):58-61; 1993a.
8. Ershler, W.B. The influence of an aging immune system on cancer incidence and progression. J. Gerontol. Biol. Sci. 48:B3-B7; 1993b.
9. Ershler, W.B.; Socinski, M.A.; Creene, C.J. Bronchogenic cancer, metastasis and aging. J. Am. Geriatr. Soc. 31:673-676; 1983.
10. Ershler, W B.; Stewart, J.A ; Hacker, M.P.; Moore, A.L.; Tindle, B.H. B16 murine melanoma and aging: slower growth and longer survival in old mice. J. Natl Cancer Inst 72:161-163; 1984a.
11. Ershler, W.B.; Garnelli, R.L.; Moore, A.L.; Hacker, M.P.; Blow, A.J. Experimental tumours and aging local factors that may account for the observed age advantage in the B16 melanoma model. Exp. Gerontol. 19:367-376; 1984b.
12. Fentiman, I.S. Treatment of cancer in the elderly. Br. J. Cancer 64:993-995; 1991.
13. Geddes, D.M. The natural history of lung cancer: a review based on rates of tumour growth. Br J Dis Chest 73:1-4; 1979.
14. Green, M.R. New adjuvant strategies for the management of resectable non-small cell lung cancer Chest 103 (suppl):352s-355s: 1993.
15. Hermanek, P.; Sobin, L.H., eds. TNM classification of malignant tumours, 4th ed. Berlin: Springer-Verlag, 1987.
16. Holmes, F.F. Clinical evidence for a change in tumor aggressiveness with age. Semin. Oncol. 16:34-40; 1989.
17. Kaesberg, P.R.; Ershler, W.B. The change in tumor aggressiveness with age: lessons from experimental animals. Semin. Oncol. 16:28-33; 1989.
18. Kim, Y.T.; Schwab, R.; Siskind, G.W.; Weksler, M E. Cellular basis for the slower growth of the B16 melanoma in old mice. Aging: Immunol. Infect. Dis. 1:237-244; 1989.
19. Kreisle, R.; Stabler, B.A., Ershler, W.B. Effect of host age on tumour-associated angiogenesis in mice. J. Natl. Cancer Inst. 82:44-47; 1990.
20. Martini, N. Surgical treatment of lung cancer. Semin. Oncol. 17:9-10; 1990.
21. McDuffie, H.H.; Klaassen, D.J. Dosman, J.A. Female-male differences in patients with primary lung cancer. Cancer 59:1825-1830; 1987.
22. McDuffie, H.H.; Klaassen, D.J.; Dosman, J.A. Determinants of cell type in patients with cancer of the lungs. Chest 98:1187-1193; 1990.
23. Mountain, C.F. Lung cancer staging classification. Clin. Chest Med. 14:43-53; 1993.
24. Murren, J.R.; Buzaid, A.C. Chemotherapy and radiation for the treatment of non-small cell lung cancer. A critical review. Clin. Chest Med. 14:161-171; 1993.
25. National Cancer Institute. Surveillance, Epidemiology and End Results program (SEER) NIH pub. no. 90-2789. Bethesda, MD: National Cancer Institute, 1989.
26. O'Rourke, M.A.; Feussner, J.R.; Feigl, P.; Laszio, J. Age trends of lung cancer stage at diagnosis. Implications for lung cancer screening in the elderly. JAMA 258:921-926, 1987.
27. Parkin, D M. Trends in lung cancer incidence worldwide. Chest 96 (suppl):5s-8s; 1989.
28. Pendleton, N.; Myskow, M. W.; Green, J. A.; Lye, M. Proliferation indices in the non-small cell lung cancers of the elderly: a comparison with a non-elderly group. Age Ageing 22 (suppl):21a; 1993.
29. Shields, T.W. Surgical therapy for cancinoma of the lung. Clin. Chest Med. 14.121-147; 1993
30. Splinter, T.A.W. Therapy for small cell and non-small cell lung cancer. Curr. Opin. Oncol. 4:315-332; 1992.
31. Stanley, K.; Stjernsward, J. Lung cancer - a worldwide health problem. Chest 96 (suppl):1s-5s, 1989.
32. Steeg, P.S. Invasion and metastasis. Curr. Opin. Oncol 4 134-141; 1992.
33. Teeter, S.M.; Holmes, F.F ; McFarlane, M.J. Lung carcinoma in the elderly population. Influence of histology on the inverse relationship of stage to age. Cancer 60:1331-1336; 1987.
34. Weiss, W.; Boucot, K.R.; Cooper, D. A. The histopathology of bronchogenic carcinoma and its relation to growth rate, metastasis and prognosis. Cancer 26:965-970; 1970.
35. WHO (World Health Organization). The World Health Organization histological typing of lung tumours. Am. J. Clin. Pathol. 77:123-136; 1982.
36. Yuhas, J.M.; Pazimo, N.H.; Procter, J.O.; Toya, R E. A direct relationship between immune competence and the subcutaneous growth rate of a malignant murine lung tumour. Cancer Res. 34:722-728; 1974.